Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 7:15 pm Sale | 13G | ASLAN Pharmaceuticals Ltd ASLN | Lind Global Fund II LP | 0 0.000% | -1,250,000 (Position Closed) | View |
| 2024-11-14 4:05 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | K2 HealthVentures Equity Trust LLC | 61,535,383 9.990% | 39,067,708 (+173.88%) | View |
| 2024-03-21 4:42 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | INTRACOASTAL CAPITAL LLC | 25,000,000 4.400% | 25,000,000 (New Position) | View |
| 2024-03-19 4:30 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | Lind Global Fund II LP | 1,250,000 5.700% | 1,250,000 (New Position) | View |
| 2024-02-14 4:45 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | K2 HealthVentures Equity Trust LLC | 22,467,675 5.200% | 22,467,675 (New Position) | View |
| 2024-02-14 10:22 am Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | BIOTECHNOLOGY VALUE FUND L P | 43,344,975 9.990% | 43,344,975 (New Position) | View |
| 2024-02-06 10:38 am Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | UBS Group AG UBS | 16,917,600 8.910% | 16,917,600 (New Position) | View |
| 2024-01-02 4:00 pm Sale | 13G | ASLAN Pharmaceuticals Ltd ASLN | TANG CAPITAL PARTNERS LP | 6,134,975 1.500% | -39,020,205 (-86.41%) | View |
| 2023-07-13 4:57 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | TANG CAPITAL PARTNERS LP | 45,155,180 11.000% | 45,155,180 (New Position) | View |
| 2023-03-20 5:20 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | K2 HealthVentures Equity Trust LLC | 26,466,126 6.200% | 26,466,126 (New Position) | View |
| 2023-03-06 5:10 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | BIOTECHNOLOGY VALUE FUND L P | 42,440,000 9.990% | 42,440,000 (New Position) | View |
| 2023-02-14 4:00 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | TANG CAPITAL PARTNERS LP | 26,824,625 7.800% | 26,824,625 (New Position) | View |
| 2023-02-14 10:24 am Sale | 13G | ASLAN Pharmaceuticals Ltd ASLN | RTW INVESTMENTS LP | 0 0.000% | -16,250,000 (Position Closed) | View |
| 2022-04-21 4:00 pm Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | TANG CAPITAL MANAGEMENT LLC | 18,796,125 5.400% | 18,796,125 (New Position) | View |
| 2022-02-14 08:53 am Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | RTW INVESTMENTS LP | 16,250,000 6.800% | 16,250,000 (New Position) | View |
| 2021-02-11 06:04 am Purchase | 13G | ASLAN Pharmaceuticals Ltd ASLN | Temasek Holdings (Private) Ltd | 8,762,260 4.600% | 371,885 (+4.43%) | View |